Financial Performance - Total revenue for Q1 2025 was 4.3million,adecreaseof23.73.7 million, down 0.8millionor17.40.9 million or 19.1% from Q4 2024[5] - Mature product revenue was 0.6million,comparedto1.1 million in Q1 2024 and 1.0millioninQ42024[6]−GAAPnetlossforQ12025was(2.2 million), or (0.14)pershare,comparedtonetincomeof0.1 million, or 0.01pershare,inQ12024[8]−Non−GAAPoperatinglossforQ12025was991 thousand, compared to a profit of 1,598thousandinQ12024,representingasignificantdecline[26]−USGAAPnetlossfromcontinuingoperationsforQ12025was2,090 thousand, compared to a profit of 73thousandinQ12024,reflectingasubstantialdownturn[26]−Non−GAAPnetincome(loss)fromcontinuingoperationspershare,basic,was(0.07) in Q1 2025, down from 0.11inQ12024[26]−Thecompanyreportedanon−GAAPnetincome(loss)of(1,146) thousand for Q1 2025, compared to 1,732thousandinQ12024,indicatingasignificantdropinperformance[26]MarginsandProfitability−GAAPgrossmarginforQ12025was43.429,604 million as of December 29, 2024, to 25,337millionasofMarch30,2025,adeclineofapproximately15.327,046 million as of December 29, 2024, to 22,760millionasofMarch30,2025,areductionofapproximately15.921,859 million as of December 29, 2024, to 17,546millionasofMarch30,2025,adeclineofapproximately19.51.4 million in Incremental Funding Modification for its Strategic Radiation Hardened Program[10] - The maturity date of a $20 million credit facility was extended from December 31, 2025, to December 31, 2026, for enhanced operational flexibility[10] - The company expects to capitalize on increasing interest from US Military, Aerospace, and Government sectors with its new offerings[3]